Basking Biosciences Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $55M

  • Investors
  • 12

Basking Biosciences General Information

Description

Developer of a reversible thrombolytic therapy designed to restore blood flow to the brain during ischemic stroke. The company's therapy uses paired therapy that combines an active agent targeting a key component of clot stability with a rationally designed reversal agent that can be administered in the event of bleeding to neutralize the active compound and restore the blood's normal clotting ability, enabling healthcare professionals to offer treatment for acute ischemic stroke to patients.

Contact Information

Website
www.baskingbiosciences.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 964 High House Road
  • Suite 3268, Durham
  • Cary, NC 27513
  • United States
+1 (919)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 964 High House Road
  • Suite 3268, Durham
  • Cary, NC 27513
  • United States
+1 (919)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Basking Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 31-Oct-2023 $55M Completed Clinical Trials - Phase 1
3. Seed Round 18-Aug-2021 Completed Clinical Trials - Phase 1
2. Grant 01-Jun-2020 $1.66M $75K Completed Clinical Trials - Phase 1
1. Accelerator/Incubator 01-Jan-2019 $75K $75K Completed Clinical Trials - Phase 1
To view Basking Biosciences’s complete valuation and funding history, request access »

Basking Biosciences Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
To view Basking Biosciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Basking Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a reversible thrombolytic therapy designed to restore blood flow to the brain during ischemic stroke. The c
Drug Discovery
Cary, NC
10 As of 2025

South San Francisco, CA
 

Portland, OR
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Basking Biosciences Competitors (34)

One of Basking Biosciences’s 34 competitors is Neurona Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neurona Therapeutics Formerly VC-backed South San Francisco, CA
Aronora Venture Capital-Backed Portland, OR
Avilex Pharma Venture Capital-Backed Copenhagen, Denmark
NeuroNascent Venture Capital-Backed Clarksville, MD
Anthos Therapeutics Formerly PE-Backed East Hanover, NJ
You’re viewing 5 of 34 competitors. Get the full list »

Basking Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Basking Biosciences Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
ARCH Venture Partners Venture Capital Minority
Insight Partners (New York) PE/Buyout Minority
Platanus Family Office Minority
RTW Investments Hedge Fund Minority
Solas BioVentures Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

Basking Biosciences FAQs

  • When was Basking Biosciences founded?

    Basking Biosciences was founded in 2019.

  • Where is Basking Biosciences headquartered?

    Basking Biosciences is headquartered in Cary, NC.

  • What is the size of Basking Biosciences?

    Basking Biosciences has 10 total employees.

  • What industry is Basking Biosciences in?

    Basking Biosciences’s primary industry is Drug Discovery.

  • Is Basking Biosciences a private or public company?

    Basking Biosciences is a Private company.

  • What is Basking Biosciences’s current revenue?

    The current revenue for Basking Biosciences is .

  • How much funding has Basking Biosciences raised over time?

    Basking Biosciences has raised $62.3M.

  • Who are Basking Biosciences’s investors?

    ARCH Venture Partners, Insight Partners (New York), Platanus, RTW Investments, and Solas BioVentures are 5 of 12 investors who have invested in Basking Biosciences.

  • Who are Basking Biosciences’s competitors?

    Neurona Therapeutics, Aronora, Avilex Pharma, NeuroNascent, and Anthos Therapeutics are some of the 34 competitors of Basking Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process